Researchers reviewed the healthcare literature for previously published systemic reports, clinical studies and component cost reports to compile the estimate, which is the first to estimate the full societal costs of HAIs, according to the article.
The study concludes the complete cost of HAIs makes them as problematic as leading public health issues like cancer, heart attack, stroke and diabetes and should merit substantial increases in infection control research and funding.
More Articles on Quality:
Leadership Walkarounds May Strengthen Safety Culture
ICU Admission Not Associated With MRSA Colonization
More Than Half of EDs Lack Standardized Handoffs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
